Oscar Health (OSCR) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Oscar Health is set to announce its Q2 2025 earnings on Wednesday, August 6th, with analysts predicting earnings of $0.34 per share and revenue of $2.88 billion.
• The company's shares opened at $13.81 and have a market capitalization of $3.52 billion, while analysts currently have a consensus rating of "Hold" with an average target price of $12.21.
• Recent insider trading showed that Director Elbert O. Jr. Robinson sold 25,000 shares at an average price of $16.43, indicating a significant decrease in his position by nearly 28%.

Oscar Health (NYSE:OSCR - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Wednesday, August 6th. Analysts expect Oscar Health to post earnings of $0.34 per share and revenue of $2.88 billion for the quarter. Oscar Health has set its FY 2025 guidance at EPS.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The firm had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter in the prior year, the business earned $0.62 EPS. The business's quarterly revenue was up 42.2% on a year-over-year basis. On average, analysts expect Oscar Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Stock Performance

NYSE OSCR traded down $0.47 on Friday, reaching $13.58. 20,300,812 shares of the stock were exchanged, compared to its average volume of 36,866,404. Oscar Health has a one year low of $11.20 and a one year high of $23.79. The firm has a market capitalization of $3.46 billion, a PE ratio of 48.50 and a beta of 1.86. The company's 50-day simple moving average is $15.87 and its two-hundred day simple moving average is $14.91. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on OSCR shares. Piper Sandler lowered shares of Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a report on Monday, July 14th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a report on Sunday, June 8th. Raymond James Financial lowered shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. UBS Group reissued a "sell" rating and issued a $11.00 target price (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Finally, Wells Fargo & Company lowered shares of Oscar Health from an "equal weight" rating to an "underweight" rating and cut their target price for the company from $16.00 to $10.00 in a report on Friday, July 11th. Five research analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $12.21.

Insider Buying and Selling at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director directly owned 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 24.39% of the company's stock.

Institutional Trading of Oscar Health

Several institutional investors and hedge funds have recently made changes to their positions in OSCR. Thrive Capital Management LLC raised its holdings in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Oscar Health by 39.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company's stock worth $6,169,000 after purchasing an additional 132,149 shares in the last quarter. Baird Financial Group Inc. bought a new position in Oscar Health in the first quarter worth about $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Oscar Health by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company's stock worth $2,827,000 after purchasing an additional 8,879 shares in the last quarter. Finally, Strs Ohio bought a new position in Oscar Health in the first quarter worth about $30,000. 75.70% of the stock is currently owned by institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.